Visionary leader and seasoned clinician brings 30 years of experience to the organization

DENVER – August 29, 2024 – Donor Alliance, the nonprofit organization that saves and heals lives through organ and tissue donation for transplantation in Colorado and most of Wyoming, announced today that Dan Lebovitz, M.D. has joined Donor Alliance as Chief Medical Officer. Dr. Lebovitz will join the executive team to lead Donor Alliance in fostering its strong relationships with more than 100 hospitals, advancing innovations to continue to honor donors’ lifesaving gifts, as well as growing the organization’s physician services.

“We are excited to welcome Dr. Lebovitz to our team. Donor Alliance empowers performance with passionate people, like Dr. Lebovitz, who will undoubtedly make a significant impact both within our organization and in the communities we serve,” said Jennifer Prinz, president and CEO, Donor Alliance. “Nearly 1,300 people in Colorado and Wyoming continue to wait for a lifesaving organ transplant and tens of thousands more need a tissue transplant. Dr. Lebovitz’s leadership and experienced clinical perspective will help give those needing a transplant hope for the future.”

With more than three decades of experience, Dr. Lebovitz brings an extensive background in organ donation, transplantation and pediatric critical care. Prior to joining Donor Alliance, he served as an Associate Medical Director of the Division of Critical Care at Akron Children’s Hospital in Ohio. He also served in a variety of director roles for organ procurement organizations across the nation, including Medical Director of the Oklahoma Organ Sharing Network (now Lifeshare Oklahoma); Medical Director, Board Chair, and Medical Advisory Board Chair of Lifebanc in Cleveland; and Associate/Consulting Medical Director of Mid-South Transplant.

Dr. Lebovitz is a member of numerous professional organizations, including the Society of Critical Care Medicine, the Network and Alliance of Transplant Coordinators, Donation and Transplantation Alliance, and American Society of Transplant Surgeons. He has also served on numerous committees and boards of United Network for Organ Sharing, Association of Organ Procurement Organizations, The Donation and Transplantation Alliance, and American Society of Transplant Surgeons. Additionally, he was a founding member of the Organ Donation Research Consortium.

Dr. Lebovitz earned his Doctor of Medicine (M.D.) at Duke University School of Medicine. He completed his Residency and Fellowship training at Rainbow Babies and Children’s Hospital in Cleveland. He is certified in general pediatrics and pediatric critical care medicine by the American Board of Pediatrics. Throughout his career his primary research, which has been published, has focused on organ donation.

About Donor Alliance

Donor Alliance is a non-profit organization dedicated to saving and healing lives through organ and tissue donation for transplantation in Colorado and most of Wyoming. As a federally designated organ procurement organization – one of 56 in the U.S. – Donor Alliance serves more than 6.3 million residents and more than 100 hospitals. Donor Alliance walks alongside the family during the organ recovery process and ensures their loved one’s gifts are safely received at transplant centers in a timely manner. Donor Alliance also facilitates tissue donation to save and heal more lives across our community. The organization also manages the Donate Life Colorado and Donate Life Wyoming registries. Through Donate Life, the symbol of the cause, Donor Alliance educates residents on the lifesaving benefits of donation, inspiring them to register. For more information, please visit DonorAlliance.org.

###

The time period between the cessation of blood flow to an organ (e.g., after cardiac death) and the start of cold preservation. Minimizing warm ischemic time is critical in preserving organ viability for transplantation.

An organization dedicated to advancing research and education in kidney disease and transplantation, contributing to the knowledge base that informs best practices in organ donation and transplantation, ultimately improving outcomes for patients with kidney failure.

This refers to a situation where a potential organ donor has given consent for donation, but for various reasons, their organs are not ultimately used for transplantation. Reasons for UAC can include medical complications, changes in the donor’s condition, or logistical issues.

The volume of urine produced by a patient’s body over a specific time period. Monitoring urine output is crucial in assessing kidney function, especially in potential organ donors and transplant recipients.

A secure, encrypted connection over a public network, like the internet. In the context of organ donation, VPNs can be used by OPOs and transplant centers to securely access and share sensitive patient data, ensuring confidentiality and compliance with regulations.

A laboratory or division of Eurofins that provides testing services related to organ donation and transplantation. These services can include donor screening, recipient testing, and post-transplant monitoring to ensure the safety and success of organ transplantation.

UNOS is a private, non-profit organization that operates the OPTN under contract with the federal government, managing the national organ transplant system and maintaining the waitlist.

A standardized format for exchanging information electronically about organ offers and acceptances.

An individual who has received a donated organ or tissue to replace their own failing organ or tissue.

The Uniform Anatomical Gift Act (UAGA) is a state and federal law that establishes the legal framework for donating organs and tissues after death.

A model state law that establishes the legal criteria for determining death, including brain death, which is crucial for organ donation after cardiac death.